Articles From: NxStage Announces FDA Clearance of Single Needle Technology to O'Reilly Automotive, Inc. Announces Additional $500 Million Share Repurchase Authorization


Innovative needle design to enhance patient safety LAWRENCE, Mass.
Sign-up for NxStage Announces FDA Clearance of Single Needle Technology investment picks
NxStage Patient Advocates to travel the East Coast to share the benefits of home hemodialysis LAWRENCE, Mass.
Sign-up for NxStage Drives to Educate Kidney Patients investment picks
NxStage Patients embrace the flexibility of home hemodialysis to reclaim their lifestyles and live freely LAWRENCE, Mass.
Sign-up for NxStage Joins Patients in Celebrating Independence investment picks
2014/7/8
Special Guest Recording Artist and Former NxStage System One patient, David RUSH LAWRENCE, Mass.
Sign-up for NxStage Kidney Care Hosts Grand Opening Celebration Of New State-Of-The-Art Dialysis Center In Jacksonville investment picks
LAWRENCE, Mass.
Sign-up for NxStage Kidney Care Opens New Orlando Florida Dialysis Center investment picks
Portability of System One allows four riders to travel to Oregon and dialyze during the ride LAWRENCE, Mass.
Sign-up for NxStage Patients Participate in 257-Mile Tour DaVita Bike Ride investment picks
--Revenue Increases to $74.1 million, up 13% from Q2'13 --Home Revenue Increases to $38.5 million, up 18% from Q2'13 --Company Expects to Top 15% Annual Growth Target for Home in 2014 --Company Increases Full-Year 2014 Revenue Guidance to be between $290 and $293 million LAWRENCE, Mass.
Sign-up for NxStage Reports Record Second Quarter 2014 Financial Results And Increases Full-Year Revenue Guidance investment picks
LAWRENCE, Mass.
Sign-up for NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference investment picks
LAWRENCE, Mass.
Sign-up for NxStage® to Report Second Quarter 2014 Financial Results investment picks
2014/9/26
BOSTON , Sept.
Sign-up for NXT-ID (NXTD) Research Note Update from SoundView; New Funding Keeps Wocket Rolling investment picks
Assuming 5 payments a day, Wocket™ will not require recharging for over a year SHELTON, Conn., August 11, 2014 /PRNewswire/ -- NXT-ID, Inc. (OTCBB: NXTD) (OTCQB:NXTD), a biometric authentication company focused on the growing mobile commerce market, announced today that its Wocket™ Smart Wallet will now contain a rechargeable battery with the calculated time between charges for the average user at over a year.
Sign-up for NXT-ID Announces Rechargeable Battery for its Wocket™ Smart Wallet investment picks
SHELTON, Conn.
Sign-up for NXT-ID Commences Trading on NASDAQ Capital Market investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1143951&ProfileId=051205&sourceType=1 SHELTON, CT --
Sign-up for NXT-ID Commences Trading on NASDAQ Capital Market investment picks
SHELTON, Conn.
Sign-up for NXT-ID Issues Shareholder Corporate Update investment picks
http://media.marketwire.com/attachments/201409/79792_NXTIDlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1146931&ProfileId=051205&sourceType=1 SHELTON, CT --
Sign-up for NXT-ID Marketing Update for Wocket(TM) Smart Wallet investment picks
National CNBC Ad Campaign Resumes, Wocket to Exhibit at 2015 CES (Consumer Electronics Show) SHELTON, Conn.
Sign-up for NXT-ID Marketing Update for Wocket™ Smart Wallet investment picks
2014/9/17
SHELTON, Conn.
Sign-up for Nxt-ID, Inc. Announces Closing of Public Offering of Common Stock and Warrants investment picks
Next Generation Wocket Smart Wallet Takes on Big Bulky Outdated Wallets SHELTON, Conn., July 17, 2014 /PRNewswire/ -- NXT-ID, Inc., (OTCBB: NXTD) (OTCQB: NXTD) a biometric authentication company focused on the growing m-commerce market, announces its consumer social media competition for its next generation smart wallet, Wocket™, "Show us your Wallet", begins Friday July 18 th .
Sign-up for NXT-ID's Consumer Facebook, Twitter and Instagram Competition "Show Us Your Wallet", #Needawocket, Begins Friday July 18th investment picks
Trulia (NYSE: TRLA), a leading online marketplace for home buyers, sellers, renters, and real estate professionals has signed an agreement with NY State MLS - which has more than 10,000 members and serves all 62 counties in New York - to ensure they can accurately market their listings to Trulia’s audience of 54 million unique monthly visitors.
Sign-up for NY State MLS Becomes Latest to Partner With Trulia to Directly Display Home Listings, Drive Value for Members investment picks
HASBROUCK HEIGHTS, N.J., July 15, 2014 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today the closing of enrollment for Study NX02-0022, the Company's second re-injection Phase 3 clinical trial of the safety and efficacy of NX-1207 for the treatment of enlarged prostate (benign prostatic hyperplasia or BPH). The NX02-0022 study enrolled patients who had previously participated in an earlier NX-1207 BPH study, and in the new trial these men received a second open-label injection of NX-1207.
Sign-up for Nymox Announces Completion of Enrollment for Second BPH Re-Injection Study investment picks
HASBROUCK HEIGHTS, N.J., July 22, 2014 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) is pleased to announce new positive efficacy data for U.S. Study NX02-0022, the Company's repeat injection study of NX-1207 for BPH.
Sign-up for Nymox Announces Positive Efficacy Results in Phase 3 Repeat Injection Trial of NX-1207 for BPH investment picks
HASBROUCK HEIGHTS, N.J., Sept.
Sign-up for Nymox Announces Positive Prostate Cancer 8 Month Clinical Trial Results investment picks
HASBROUCK HEIGHTS, N.J., June 17, 2014 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) is pleased to report new data supporting the positive sexual functional preservation profile of NX-1207, the Company's lead compound in Phase 3 development for the treatment of prostate enlargement (BPH or benign prostatic hyperplasia) and Phase 2 development for localized prostate cancer.
Sign-up for Nymox Reports Positive Update on Nerve Sparing and Sexual Function Preservation in Men Treated With NX-1207 investment picks
HASBROUCK HEIGHTS, N.J., Aug.
Sign-up for Nymox Reports Second Quarter 2014 Financial Results investment picks
SUNNYVALE, Calif.
Sign-up for O.C. Kwon Elected to Spansion Board of Directors investment picks
ST. PETERSBURG and ATLANTA, Aug.
Sign-up for O'KEY to Capitalize on Growth Opportunity in Russia with Manhattan Associates Supply Chain Commerce Platform investment picks
SPRINGFIELD, Mo., Aug.
Sign-up for O'Reilly Automotive, Inc. Announces Additional $500 Million Share Repurchase Authorization investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: NxStage Announces FDA Clearance of Single Needle Technology to O'Reilly Automotive, Inc. Announces Additional $500 Million Share Repurchase Authorization
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices